Morgan Stanley offers leveraged single-country exposure to China

Single country exposure to China is rare in the US

The most recent US product offering includes a China-based accelerated growth product from Morgan Stanley that is unusual in that it links to a single country rather than the broad emerging markets exposure that is more common in the US.

The Morgan Stanley product tracks the iShares FTSE/Xinhua China 25 Index Fund. It has a 13-month term and provides 300% participation in the underlying, with a cap at 18.4%.

Compared with recent issuances, which have featured a rash of products with extended ten

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: